Navigation Links
Institute for Neurodegenerative Disorders Deploys OpenClinica EDC solution for Large Parkinson's Study
Date:3/12/2009

OpenClinica has been deployed as the electronic data capture and clinical data management system for a Parkinson's study that could involve up to 15,000 patients.

New Haven, CT (PRWEB) March 12, 2009 -- The Institutive for Neurodegenerative Disorders (IND) announces that has deployed the OpenClinica clinical data capture and management software for the Parkinson's Associated Risk Study (PARS).

PARS is a clinical study to develop a pre-motor Parkinson disease (PD) cohort using a combination of olfactory testing and dopamine transporter imaging to detect those at risk for PD. This ambitious project will recruit up to 15,000 study subjects from throughout the US who will participate in predictive testing. For more information about the PARS study, see http://www.parsinfosource.com/index.htm.

IND has selected OpenClinica to streamline clinical data collection and management for this clinical trial. Through the OpenClinica Enterprise program, the PARS study will receive a certified implementation of OpenClinica electronic data capture system, customization of certain features, training for users, and ongoing support for the popular open source eClinical software.

"We are excited about the progress of the PARS study and our collaboration with OpenClinica in this and other research studies sponsored by the Institute," said Dr. Danna Jennings, Clinical Research Director at IND. "In the PARS study, data management is a crucial component of success and OpenClinica has provided a flexible and versatile platform that will ensure the quality and consistency of the PARS data."

Through OpenClinica Enterprise, an organization conducting clinical research can obtain a spectrum of services to enhance their use of the OpenClinica software. OpenClinica Enterprise enables a research institution to maintain its independence from software vendors while obtaining full support for a modern, robust clinical research software technology.

About the Institute for Neurodegenerative Disorders
The Institute for Neurodegenerative Disorders (IND) is an independent not-for-profit research institute located in New Haven, Connecticut. The mission of IND is to develop improved treatments, diagnostic tools and educational programs for neurologic disorders such as Parkinson disease, Huntington disease and Alzheimer disease through clinical research.

IND specializes in clinical and neuroimaging research and is developing tools to diagnose neurologic disorders at the earliest possible stages of disease. IND also conducts large multi-center studies aimed at understanding medications that may influence the influence the disease's rate of progression. For more information see http://www.indd.org.

About OpenClinica®
OpenClinica is open source web-based electronic data capture software for clinical research. It facilitates protocol configuration, design of case report forms, clinical data capture, and study/data management. OpenClinica supports HIPAA, GCP, and 21 CFR Part 11 guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. OpenClinica is available for download at http://www.openclinica.org.

About Akaza Research®
Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH) and dozens of other leading research institutions, Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data capture and management software platform. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for private and public research. Akaza Research provides OpenClinica support, training, and consulting services to its customers worldwide. See http://www.akazaresearch.com.

###

Read the full story at http://www.prweb.com/releases/clinical_trials_software/electronic_data_capture/prweb2223244.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Netherlands Vaccine Institute Chooses TrackWise(R) Solution for Enterprise-wide Compliance with Good Manufacturing Practices
2. Ventura County Star Newspaper Honors Khanna Institute
3. BancTec Provides Thought Leadership at 7th Annual Medical Banking Institute
4. The REACH Institute: Best Practice Guidelines Address Mental Health Needs of Youth in Care
5. Aspen Institute to Introduce Roadmap for Responsible Health Care Reform, New Coalition To Call For Sustainable Improvements
6. Karmanos Cancer Institute Announces Interim Leadership
7. SXC Health Solutions Awarded The Pharmacy Benefit Management Institutes 2009 Innovation Award
8. The Texas Institute of Dermatology Team Finds Easy-to-Apply, Topical Drug Just as Good as Injectable Compound for a Disfigurating Skin Infection
9. Johnson Institute Transfers Key Programs and Products to Hazelden Foundation
10. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in Nation to Use NaviStar(R) RMT ThermoCool(R) Catheter Since Technology Received FDA Approval
11. Cambridge Healthtech Institute Announces Its Premiere Collaborative Innovation in Biomedicine Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Institute for Neurodegenerative Disorders Deploys OpenClinica EDC solution for Large Parkinson's Study
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... has received a new patent for its innovative Secure Messaging platform, which includes ... control. The new patent extends Cirius’s portfolio of patents around innovative features ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... wellness and sleep disorder management, today announced it has secured $9 million in ... (WiL) and existing investors. The investment will be used by Somnoware to further ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... announced today the introduction of the innovative newly improved Iso-Hip Wrap. The ... patients. The plush design enhances comfort and enables the patient to enjoy the ...
(Date:5/4/2016)... ... May 04, 2016 , ... a2z, Inc. ... Society™ and Canadian Association for Enterostomal Therapy (CAET) will be utilizing powerful and ... tools to attendees and exhibitors for the 2016 WOCN Society & CAET Joint ...
(Date:5/4/2016)... ... 04, 2016 , ... Washington Wellness Center today announced its tenth anniversary of ... What started out as an idea to provide a holistic approach to wellness has ... Developed by Dr. David Swanekamp, Chiropractic Physician , the wellness center offers a ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... DUBLIN , May 4, 2016 ... the "Global Cancer Stem Cell Therapy Market Outlook ... (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has ... therapeutics are expected to be developed in coming years. ... these techniques. Cancer stem cell therapies are also expected ...
(Date:5/3/2016)... , May 3, 2016  As a teenager, ... contracted rheumatic fever, which damaged his heart. He continued ... But by June 2013, Shepherd,s heart was giving out ... death. On June 20, 2013, the Mesa, ... Artificial Heart (TAH-t). Like a heart transplant, the SynCardia ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
Breaking Medicine Technology: